Annual SGA
$30.09 M
+$8.18 M+37.32%
September 30, 2024
Summary
- As of February 23, 2025, CTXR annual SGA is $30.09 million, with the most recent change of +$8.18 million (+37.32%) on September 30, 2024.
- During the last 3 years, CTXR annual SGA has risen by +$18.80 million (+166.48%).
- CTXR annual SGA is now at all-time high.
Performance
CTXR SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$7.91 M
-$223.00 K-2.74%
December 31, 2024
Summary
- As of February 23, 2025, CTXR quarterly SGA is $7.91 million, with the most recent change of -$223.00 thousand (-2.74%) on December 31, 2024.
- Over the past year, CTXR quarterly SGA has stayed the same.
- CTXR quarterly SGA is now -2.74% below its all-time high of $8.14 million, reached on September 30, 2024.
Performance
CTXR Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$783.10 M
-$39.68 M-5.34%
December 31, 2024
Summary
- As of February 23, 2025, CTXR TTM SGA is -$783.10 million, with the most recent change of -$39.68 million (-5.34%) on December 31, 2024.
- Over the past year, CTXR TTM SGA has dropped by -$814.38 million (-2603.28%).
- CTXR TTM SGA is now -2002701.79% below its all-time high of -$39.10 thousand.
Performance
CTXR TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CTXR Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +37.3% | 0.0% | -2603.3% |
| 3 y3 years | +166.5% | 0.0% | -2603.3% |
| 5 y5 years | +329.8% | 0.0% | -2603.3% |
CTXR Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +166.5% | -2.7% | +114.3% | -107.3% | at low |
| 5 y | 5-year | at high | +329.8% | -2.7% | +343.7% | -267.4% | at low |
| alltime | all time | at high | >+9999.0% | -2.7% | >+9999.0% | <-9999.0% | at low |
Citius Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $7.91 M(-2.7%) | $31.28 M(+4.0%) |
| Sep 2024 | $30.09 M(+37.3%) | $8.14 M(+3.4%) | $30.09 M(+3.1%) |
| Jun 2024 | - | $7.87 M(+6.9%) | $29.20 M(+11.3%) |
| Mar 2024 | - | $7.36 M(+9.6%) | $26.23 M(+5.7%) |
| Dec 2023 | - | $6.72 M(-7.2%) | $24.83 M(+13.3%) |
| Sep 2023 | $21.91 M(+39.9%) | $7.24 M(+47.6%) | $21.91 M(+19.3%) |
| Jun 2023 | - | $4.91 M(-17.6%) | $18.36 M(+5.0%) |
| Mar 2023 | - | $5.96 M(+56.6%) | $17.48 M(+11.6%) |
| Dec 2022 | - | $3.80 M(+3.0%) | $15.66 M(+0.0%) |
| Sep 2022 | - | $3.69 M(-8.3%) | $15.66 M(+5.3%) |
| Sep 2022 | $15.66 M(+38.7%) | - | - |
| Jun 2022 | - | $4.03 M(-2.7%) | $14.88 M(+1.7%) |
| Mar 2022 | - | $4.14 M(+8.9%) | $14.63 M(+11.4%) |
| Dec 2021 | - | $3.80 M(+30.7%) | $13.13 M(+16.3%) |
| Sep 2021 | $11.29 M(+26.9%) | $2.91 M(-23.1%) | $11.29 M(+2.3%) |
| Jun 2021 | - | $3.78 M(+43.4%) | $11.04 M(+18.7%) |
| Mar 2021 | - | $2.64 M(+34.2%) | $9.30 M(+2.4%) |
| Dec 2020 | - | $1.97 M(-25.9%) | $9.08 M(+2.0%) |
| Sep 2020 | $8.90 M(+27.1%) | $2.65 M(+29.7%) | $8.90 M(+12.9%) |
| Jun 2020 | - | $2.04 M(-15.4%) | $7.88 M(+5.1%) |
| Mar 2020 | - | $2.42 M(+35.5%) | $7.50 M(+6.8%) |
| Dec 2019 | - | $1.78 M(+8.8%) | $7.03 M(+0.3%) |
| Sep 2019 | $7.00 M(-3.1%) | $1.64 M(-1.3%) | $7.00 M(-3.9%) |
| Jun 2019 | - | $1.66 M(-14.5%) | $7.29 M(+6.1%) |
| Mar 2019 | - | $1.94 M(+10.4%) | $6.86 M(+8.1%) |
| Dec 2018 | - | $1.76 M(-8.5%) | $6.35 M(-12.1%) |
| Sep 2018 | $7.23 M | $1.92 M(+55.2%) | $7.23 M(-0.1%) |
| Jun 2018 | - | $1.24 M(-13.2%) | $7.23 M(-10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $1.43 M(-45.9%) | $8.06 M(-3.1%) |
| Dec 2017 | - | $2.64 M(+36.7%) | $8.31 M(+17.9%) |
| Sep 2017 | $7.05 M(+56.1%) | $1.93 M(-6.6%) | $7.05 M(+6.7%) |
| Jun 2017 | - | $2.06 M(+22.6%) | $6.61 M(+5.1%) |
| Mar 2017 | - | $1.68 M(+22.6%) | $6.29 M(+14.8%) |
| Dec 2016 | - | $1.37 M(-7.4%) | $5.47 M(+21.2%) |
| Sep 2016 | $4.52 M(+215.2%) | $1.48 M(-15.0%) | $4.52 M(+33.7%) |
| Jun 2016 | - | $1.75 M(+100.2%) | $3.38 M(+69.6%) |
| Mar 2016 | - | $871.90 K(+109.8%) | $1.99 M(+37.7%) |
| Dec 2015 | - | $415.50 K(+20.0%) | $1.45 M(+1.0%) |
| Sep 2015 | $1.43 M(+4999.3%) | $346.20 K(-3.4%) | $1.43 M(+31.9%) |
| Jun 2015 | - | $358.20 K(+9.6%) | $1.09 M(+48.9%) |
| Mar 2015 | - | $326.70 K(-18.7%) | $729.80 K(+61.1%) |
| Dec 2014 | - | $401.80 K(>+9900.0%) | $452.90 K(+254.9%) |
| Jun 2014 | - | $1300.00(-97.4%) | $127.60 K(-1.6%) |
| Mar 2014 | - | $49.80 K(-19.4%) | $129.70 K(+45.4%) |
| Dec 2013 | - | $61.80 K(+320.4%) | $89.20 K(+218.6%) |
| Sep 2013 | $28.10 K(+43.4%) | $14.70 K(+332.4%) | $28.00 K(+57.3%) |
| Jun 2013 | - | $3400.00(-63.4%) | $17.80 K(-13.6%) |
| Mar 2013 | - | $9300.00(+1450.0%) | $20.60 K(+14.4%) |
| Dec 2012 | - | $600.00(-86.7%) | $18.00 K(-8.2%) |
| Sep 2012 | $19.60 K(-23.4%) | $4500.00(-27.4%) | $19.60 K(+12.0%) |
| Jun 2012 | - | $6200.00(-7.5%) | $17.50 K(-4.9%) |
| Mar 2012 | - | $6700.00(+204.5%) | $18.40 K(-2.1%) |
| Dec 2011 | - | $2200.00(-8.3%) | $18.80 K(-26.6%) |
| Sep 2011 | $25.60 K | $2400.00(-66.2%) | $25.60 K(+10.3%) |
| Jun 2011 | - | $7100.00(0.0%) | $23.20 K(+44.1%) |
| Mar 2011 | - | $7100.00(-21.1%) | $16.10 K(+78.9%) |
| Dec 2010 | - | $9000.00 | $9000.00 |
FAQ
- What is Citius Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual SGA year-on-year change?
- What is Citius Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly SGA year-on-year change?
- What is Citius Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals TTM SGA year-on-year change?
What is Citius Pharmaceuticals annual SGA?
The current annual SGA of CTXR is $30.09 M
What is the all time high annual SGA for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual SGA is $30.09 M
What is Citius Pharmaceuticals annual SGA year-on-year change?
Over the past year, CTXR annual SGA has changed by +$8.18 M (+37.32%)
What is Citius Pharmaceuticals quarterly SGA?
The current quarterly SGA of CTXR is $7.91 M
What is the all time high quarterly SGA for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly SGA is $8.14 M
What is Citius Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, CTXR quarterly SGA has changed by $0.00 (0.00%)
What is Citius Pharmaceuticals TTM SGA?
The current TTM SGA of CTXR is -$783.10 M
What is the all time high TTM SGA for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high TTM SGA is -$39.10 K
What is Citius Pharmaceuticals TTM SGA year-on-year change?
Over the past year, CTXR TTM SGA has changed by -$814.38 M (-2603.28%)